The plasma anion gap is a frequently used parameter in the clinical diagnosis of a variety of conditions. The commonest application of the anion gap is to classify metabolic acidosis into those that do or do not leave unmeasured anions in the plasma. While this algorithm is useful in streamlining the diagnostic process, it should not be used solely in this fashion. The anion gap measures the difference between the unmeasured anions and unmeasured cations and thus conveys much more information to the clinician than just quantifying anions of strong acids. In this review, the significance of the anion gap is emphasized and several examples are given to illustrate a more analytic approach to using the clinical anion gap. These include disorders of low anion gap, respiratory alkalosis and pyroglutamic acidosis.
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Practice Points

•
The anion gap measures the difference between all unmeasured anions other than HCO 3 - and Cl -, and all unmeasured cations other than Na + .
• The clinical utility of the anion gap extends far beyond the differential diagnosis of metabolic acidosis.
• It is advisable that the clinician knows the normal range of the anion gap and the assays used in measuring Na + and Cl -in the laboratories supporting their practice.
• The ability to suspect and recognize that the anion gap is higher or lower than expected in a given clinical scenario allows the clinician to have much wider, sharper and more sophisticated diagnostic capabilities with information that is presented in routine chemistry reports.
Research Agenda
• The role of strong (fully dissociated at plasma pH) ions and weak (titratable with H + at plasma pH) cations and anions in determining in acid-base physiology is often unrecognized. This area deserves further data collection in whole organism physiologic and pathophysiologic settings.
• There are vast unexplored territories in how physiologic and pathophysiologic conditions alter unmeasured cation and anion concentrations in terms of their generation, metabolism, and renal handling. Work in these areas is likely to be fruitful in generating novel knowledge in acid-base-electrolyte physiology and clinical medicine.
• Pyroglutamic acidosis, particularly in milder forms, are more common than realized. The pathophysiology of the acquired form of this condition is not clear. Animal models as well as carefully performed metabolic studies in humans are much needed to understand this potentially life-threatening condition. It is likely that there are other forms of acidbase disorders that are unrecognized .
Introduction
The plasma anion gap is a calculated entity that is utilized frequently in clinical practice and is automatically displayed in most routine chemistry reports. The anion gap assumes the most central decisive role in the diagnostic algorithms of metabolic acidosis pontificated by most
textbooks. An implicit axiom is that diagnosticians have secured sufficient expertise in interpreting the biologic significance of disturbances in plasma anion gaps and are apt in 
Determinants and Significance of the Plasma Anion Gap
Although inaccurate, the term anion gap is commonly accepted in everyday clinical parlance. As charge balance precludes the existence of any gaps, the more accurate term should really be "difference between unmeasured anions and unmeasured cations" which obviously lacks the brevity requisite for practical communication. For those who share the belief that physicians have much to learn from non-mammalian biology, several excellent monographs are available for further reading about physiologic lactic acidosis and shell buffering in turtles (4-6).
The clinical conception and application of the anion gap treats it as a passive parameter in the sense that it merely reflects the replacement of HCO 3 -with an anion from a strong acid. variable rather than just a sentinel. This review will not expound this alternative position but the interested reader can find such discussions by Constable, Boyle, and Baldwin (9, 10).
Approach to a Low Anion Gap
Whereas the presence of a high anion gap educes the consideration of a differential diagnosis by reflex in daily clinical practice, a low anion gap often does not elicit the same warning to clinicians and hence often remains either undiscovered or neglected. Furthermore, the classic differential diagnosis of a low anion gap has changed since ion selective electrode has been introduced. A low anion gap has two utilities. First, it can be an early and sometimes only sign of an underlying disease process such as paraproteinemia. Second, a low anion gap can mask an underlying high anion gap acidosis and potentially delay intervention. While an increase in the anion gap is almost always caused by retained unmeasured anions, a decrease in the anion gap can be generated by multiple mechanisms.
Errors in plasma sodium. Acute dilution of the extracellular fluid with either administered or retained hypotonic fluid will theoretically dilute essentially all ions causing a fall in the anion gap. However, this type of dilution usually results only in reductions of the anion gap of 1 or 2 mEql/L which will hardly move it out of the laboratory normal range. Severe hypernatremia can be underestimated by flame photometry due to the non-linear nature of this assay. Since the measurement of plasma chloride and bicarbonate remains accurate even at increased concentrations, the net result will be a spuriously low anion gap (11, 12) . The use of sodium-selective electrodes with a larger dynamic range negates this artifact from instrument non-linearity. Large non-aqueous volumes in the plasma such as hypertriglyceridemia or dysproteinemia (12) (13) (14) (15) (16) can lead to an underestimation of serum sodium especially with flame photometric instruments. However, sodium-selective electrodes are not spared even though the sodium activity registered by the sodium electrode is oblivious to the non-aqueous volume. This is explained in Figure 1 . Automatic aspirators and dilutors prepare the samples and in situations with excessive non-aqueous volume in plasma, a smaller than expected plasma volume may be aspirated leading to an underestimation of plasma sodium during the back-calculation (Fig 1) . In the absence of concurrent errors in Cl -and HCO 3 -measurements, a low anion gap ensures. In macroglobulinemia, the error in sodium measurement is proportionate to the level of hyperviscosity and can be as high as 40 mEql/L. (17) Hypoalbuminemia. At a normal serum pH of 7.4, majority of the plasma proteins are anionic. Albumin with an average negative charge of 18 per mole at physiologic pH has been shown to be responsible for approximately 75% of the unmeasured anions of the normal anion gap (18) . A drop in albumin by 10 g/L therefore will cause the anion gap to fall by approximately 2.5 mEql/L at constant pH (19, 20) . Hypoalbuminemia is probably the commonest cause of a clinically relevant lowered anion gap. When both low anion gap and hypoalbuminemia are present, it is prudent to ensure that the low anion gap can be quantitatively accounted for by the low albumin.
Errors in plasma chloride. Hypertriglyceridemia can interfere with the colorimetric assays of serum chloride measurements due to light-scattering effects and result in marked overestimation of serum chloride. Overestimation of serum chloride by lipid interference does not occur with ion selective electrode measurements (14) . Chloride is normally the only halide present in the extracellular fluid in significant concentrations. In acute or chronic bromide ingestion, bromide slowly replaces the extracellular chloride mainly because of their differential renal tubular handling; the renal tubule seems to reabsorb bromide more avidly than chloride, leading to its accumulation in the extracellular fluid (21) . Classic sources of bromide were the bromide containing over-the-counter sedatives. More recently, pyridostigmin bromide used in the treatment of myasthenia gravis has been reported to cause bromide intoxication. (22) . The effect of plasma bromide on the anion gap depends on the methods of measurement of chloride (Table 1 ). In the titrametrical measurement assay, both halides react identically and there will be no change in the anion gap with high plasma bromide concentration (23) . With the colorimetric assays, not only are the two halides indistinguishable, bromide usually yields a deeper color than chloride giving rise an artificially high chloride concentration resulting in a low anion gap (24) .
With highly selective methods such as voltammetry (25), bromide and chloride does not crossreact and bromide intoxication presents with an elevated anion gap. By the same mechanism as bromide, another halide, iodide, can lead to changes anion gap depending on the assay methods (26) . Iodide is found in radiologic contrast material expectorants and a number of other medications. Patients with renal insufficiency are prone to retain iodide and develop iodinism.
Non-sodium cations. In addition to displacement of sodium-containing water from serum by large amounts of non-sodium-containing paraproteins, some paraproteins can have a net positive charge at physiologic pH. This leads to an increase of unmeasured cations and a low anion gap (1). Murray et al. found an correlation between the plasma anion gap and paraprotein levels and net positive charge on paraproteins in the patients with the lowest anion gaps (27) . Of the two commonest immunoglobulins in myeloma, IgG tends to be cationic while IgA tends to be anionic at physiologic plasma pH and the disturbances in anion gap seems to correspond accordingly (IgG low gap; IgA high gap) (28-30) although this correlation is not always invariable (27) (28) (29) (30) (31) (32) . One convincing piece of evidence supportive of causality is the fact that chemotherapy results in simultaneous normalization in paraprotein and anion gap (33) .
Concomitant severe hypercalcemia and hypoalbuminemia are often contributing factors to a low anion gap in multiple myeloma.
Parenteral administration of the now rarely used cationic peptide antibiotic polymyxin B can result in hyperchloremia and thereby markedly reduce the serum anion gap. (34) . Since the only cation included in the anion gap calculation is sodium, severe hyperkalemia, hypercalcemia, hypermagnesemia or lithium intoxication theoretically can also lead to a significantly decreased anion gap. Potassium and lithium are fully dissociated while calcium and magnesium exist in complexed forms that may or may not contribute cationic charges. For example, albumin bound calcium is uncharged but the calcium trivalent citrate soluble complex is a univalent anion. The key is to perform the correct calculation when assessing whether these elevated cations can quantitatively account for the low anion gap.
The Anion Gap in Respiratory Alkalosis
Not an uncommon consultation is one requesting evaluation of the following set of clinical chemistry data. In mM: Na 138, Cl 103, HCO 3 -18, yielding an anion gap of 17. Since the HCO 3 has fallen about the same degree as the anion gap has risen, the clinician may algorithmically default to asking which acid consumed the HCO 3 -and left the footprint and start searching for an anion gap metabolic acidosis. This approach is clearly too restricted. The pitfall results from the low plasma bicarbonate from renal compensation of respiratory alkalosis, the unknown normal baseline anion gap of that individual, and the slightly elevated anion gap encountered in alkalemia.
Renal compensation in the form of HCO 3 -excretion to reduce the plasma HCO 3 -in response to a low systemic pCO 2 is well documented involving both the proximal (35, 36) and distal (37, 38) nephrons. The mechanism by which this happens is unknown although one presumes a low pCO 2 pervades throughout the body and causes an intracellular alkalosis in the renal epithelial cell. Since a fall in plasma HCO 3 -can potentially rectify the plasma pH completely and the kidney is amply able to achieve that, it is unknown why the correction is always partial (i.e. plasma pH is never returned to normal). Since these issues are beyond the realm of this review, one will settle for the empirical existence of a low plasma HCO 3 -in our current discussion. We will focus on the plasma anion gap in alkalemia (high plasma pH). Three mechanisms can contribute to raising the plasma anion gap in alkalemia. Each may be small in magnitude but in combination, these can explain the 3-4 mEq/L rise encountered in clinical situations.
A small but significant elevation of plasma anion gap has been repeatedly observed in chronic respiratory alkalosis in humans (39) (40) (41) (42) . The question remains as to what is the source of this alteration. One proposed mechanism is increased plasma lactate generation. This theory is based partly on the observation that acute hyperventilation raises plasma lactate levels (43-49).
The rise in plasma lactate was quite variable in these experimental conditions and in some did The third mechanism by which alkalemia can raise plasma anion gap is via titration of plasma buffers. Albumin is frequently quoted as the main contributor of its relative abundance.
The situation is far more complex in reality. First is the fact that albumin concentration itself per se can impact on plasma acid-base status as mentioned above via the Stewart mechanism (7, 9, 10). The group of Fencl presented experimental data of this effect and termed it "hypoproteinemia alkalosis" (50, 51) . Regardless of this interaction, the question remains as to whether charge titration on albumin alone is sufficient to raise the anion gap. Non-denatured albumin has an isoelectric point of 5 and has a reasonably steep charge-to-pH relationship throughout pH 5-9 (52). However, the actual contribution of albumin to the change in anion gap observed with pH changes is quantitatively less than that predicted from titration of negative This further emphasizes the fact that changes in pH alter charges on any anion or cation provided these ions do not exist perpetually in dissociation. These are ions in Stewart's analysis (7) whose valence will change in physiologic pH. Two factors determine whether an ion will contribute to the pH-dependent change in anion gap: pK and plasma concentration of the ion. A titratable substance with a pK of 7.4 will increase its anionic composition by 25% when the pH goes to 7.5 but if this substance exists in micromolar quantities in the plasma, it will have minimal impact on the anion gap. A substance with millimolar concentrations but with a pK of 3 will have no appreciable change in its anionic content with the same pH change from 7.4 to 7.5. The ions that have clinical impact include phosphate and some organic anions that will increase their valence, and positively charged proteins such as some globulins that will decrease their valence as plasma pH rise. Both of these changes will result in an increase in the anion gap.
Pyroglutamic Acidosis-An Uncommon Severe Anion Gap Metabolic Acidosis
Although the bulk of the literature on this condition seems fairly recent, this is by no means a new clinical entity. It is most likely that pyroglutamic acidosis is just being recognized more frequently now than before. Pyroglutamic acid is natural product found in vegetables, fruits and grass and is synonymous with 5-oxoproline, glutimic acid, glutiminic acid, pyrolidone carboxylic acid, α-aminoglutaric acid lactam, and perhaps a few other names unbeknownst to the authors (Fig 2) . It is a strong acid and is a key intermediate metabolite in the γ-glutamyl cycle which will be discussed in more detail below. The plethora of aliases partially finds its way to the clinical literature so the identical condition is also called 5-oxoprolinuria. Since our interest and focus is on the systemic acid-base disturbance rather than the leakage of this substance in the urine, we will refer to this condition as pyroglutamic acidosis.
It is worth a brief mention how a neutral metabolic reaction can lead to metabolic acidosis as this pertains not only to pyroglutamic acid but the much more common lactic and ketoacidoses. This is illustrated in Figure 3 . Metabolic cascades that are neutral may contain intermediates with low pK values so they instantly dissociate into H + and the corresponding anion (shown as β-hydroxybutyrate in Fig 3) while transiting through the pathway. The H + is buffered by HCO 3 -and indeed a momentary "acidosis" develops. However, as the base is metabolized, H + is consumed in equimolar quantity as prior H + generation and acid-base balance is restored with no net gain in acid or base as expected for a neutral metabolic reaction.
However, two scenarios can convert this neutral reaction to an acid-generating process and resultant metabolic acidosis (Fig 3) . Fig 3) is to go to a sink rather than metabolized, the opportunity of consuming the H + and regenerating the base is foregone. An example of such a sink for the example given in Fig 3 is renal excretion of β-hydroxybutyrate as a Na + and/or K + salt. These two mechanisms can work in conjunction. This scheme can be applied to any metabolic reaction with intermediate products with low pKa's.
To fully understand pyroglutamic acid, one needs to revisit the γ-glutamyl cycle. The γ-glutamyl cycle has been proposed to facilitate amino acid transport into cells whereas the product glutathione has a myriad of functions including the detoxification of reactive oxygen species which are particularly important in the mitochondria. Glutathione is a tripeptide (glutamic acidcysteine-glycine) found in virtually all cells except perhaps neurons (Fig 2) . The characteristic peptide bond between glutamate and cysteine is on the γ rather than the usual α-carboxyl group that renders the bond resistant to peptidases but an excellent substrate for γ-glutamyl transpeptidase. Figure 4 summarizes the γ-glutamyl cycle. Most of the enzymes and reactions in this cycle have been confirmed by naturally occurring genetic defects and/or a wide variety of inhibitors for each enzymes (55, 56) . Glutathione acts a donor of the γ-glutamyl group to a variety of amino acids via the action of γ-glutamyltranspeptidase on the cell membrane. The γ-glutamylaminoacid is taken up into the cell and with release of the γ-glutamyl group as a lactam ringed structure, pyroglutamic acid, which is the only strong acid in this cycle. The ring is opened to glutamic acid, which then combines with cysteine to form γ-glutamylcycteine. The enzyme is γ-glutamylcycteine which is regulated tightly by glutathione levels. γ-glutamylcycteine acquires a glycine to regenerate glutathione and completes the cycle. Both congenital enzymatic defects as well as acquired conditions can lead to pyroglutamic acidosis (see below).
Regardless of the cause, the clinical syndrome is characterized by acute onset of severe metabolic acidosis of widened anion gap. Pyroglutamic acidosis has been known as a complication of congenital glutathione or 5-oxoprolinase deficiency (57) (58) (59) (60) (61) . Acquired forms of pyroglutamic acidosis has been in the literature for more over a decade associated with conditions such as dietary glycine deficiency from malnutrition or pregnancy, type 2 diabetes, hydrolyzed low lactose formula, and several medications such as antibiotics, vigabatrin, and acetaminophen (62) (63) (64) (65) (66) (67) (68) (69) (70) (71) (72) (73) (74) (75) (76) . In the largest series by Pitt and Hauser, the bicarbonate can be as low as While hippurate is processed by a filtration-secretion made in the proximal tubule (87, 88) , the renal handling of pyroglutamate is not as clear but the following analysis supports a filtration-reabsorption system (Fig 5) . Pyroglutamic acid is taken up from proximal tubule brush border membrane vesicles via a Na + -dependent carrier (81) (82) (83) . Interestingly, pyroglutamic acid seems to share transporter mechanisms with the neutral amino acid B 0+ rather than anionic amino acids X -A,G system (83) . The interaction between pyroglutamic acid and neutral amino acid may be more complex than sharing a transporter as pyroglutamic acid appears to stimulate rather than compete with the B 0+ neutral amino acid transport in the blood brain barrier (89) . Since there is no basolateral uptake of pyroglutamic acid from the plasma to the renal tubule via the basolateral membrane, the apical Na + -coupled uptake likely results in reabsorption of filtered pyroglutamate although the relatively low affinity of 20 mM (83) is unlikely to permit complete uptake.
Conclusion
In this short review, the authors wish to convey and emphasize the concept that the clinical anion gap is not a mere reflection of leftover anions of strong acids that has decomposed glutamyltransferase. Upon release of the amino acid, the γ-glutamyl group is released as a lactam structure which is pyroglutamic acid (or oxoproline). Pyroglutamic acid is a strong monocarbolylic acid and is completely dissociated at plasma pH. The ring structure is opened to release glutamate by 5-oxoprolinase. Glutathione is regenerated by subsequent addition of cysteine and glycine. Since γ-glutamylcycteine is a true γ-glutamyl amino acid, it is a substrate for γ-glutamyl cyclotransferase (#) which is a high capacity enzyme. Glutathione shuts off its own synthesis not at the immediate proximal step but via negative feedback to inhibit γ-glutamylcycteine synthetase. Both hippuric acid and pyroglutamic acid consumes a similar amount of HCO 3 -when added to plasma. Renal ammoniagenesis is stimulated but inadequate to regenerate the consumed HCO 3 -hence the acidosis. However the excretion of Hp -is much more efficient than pG -resulting in normalization of the anion gap in hippuric and not pyroglutamic acidosis. 
